Trial · NCT04769505
Mindfulness-based Interventions in COPD Patients
NCT04769505, Not applicable, Completed, Karl Landsteiner Institute for Lung Research and Pneumological Oncology
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Mindfulness-based Interventions in COPD Patients. Trials, record NCT04769505. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT04769505
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Mindfulness-based Interventions in COPD Patients
- NCT number
- NCT04769505
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 30 participants, actual
- Lead sponsor
- Karl Landsteiner Institute for Lung Research and Pneumological Oncology
- Conditions
- Chronic Obstructive Pulmonary Disease Exacerbation
- Interventions
- digital mindfulness-based intervention (MBI)
- First posted
- 2021-02-24
- Last updated
- 2024-03-18
Source ClinicalTrials.gov
Registered outcomes14
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Psychological distress | baseline - 4 weeks | Hospital Anxiety and Depression Scale (HADS; Zigmond \& Snaith, 1983; German version Herrmann-Lingen et al., 2011), scores: 0-42, lower scores indicate improvement, interpreting both subscales for anxiety and depression |
| Primary | Psychological distress | baseline - 8 weeks | Hospital Anxiety and Depression Scale (HADS; Zigmond \& Snaith, 1983; German version Herrmann-Lingen et al., 2011), scores: 0-42, lower scores indicate improvement, interpreting both subscales for anxiety and depression |
| Primary | Patient's experiences with the digital MBI | 8 weeks | patients' experiences assessed in the exit interview (qualitative and quantitative data) |
| Secondary | Chronic stress | baseline, 4 weeks, 8 weeks, 4 months, 6 months | assessed by Perceived Stress Scale (PSS-10; Cohen \& Williamson, 1988; German version Klein et al., 2016), scores 0-40, lower scores indicate improvement |
| Secondary | Health related quality of life | baseline, 4 weeks, 8 weeks, 4 months, 6 months | Chronic Respiratory Questionnaire (CRQ-SAS; German version Schünemann et al., 2003), scores: 20-140, higher scores indicate improvement |
| Secondary | Health status impairment | baseline, 4 weeks, 8 weeks, 4 months, 6 months | COPD Assessment Test (CAT; Jones et al., 2009), scores 0-40, lower scores indicate improvement |
| Secondary | Fatigue | baseline, 4 weeks, 8 weeks, 4 months, 6 months | Multidimensional Fatigue Inventory (MFI-20; German version Schwarz, Krauss, \& Hinz, 2003), scores 0-80, items have different polarity |
| Secondary | Mindfulness | baseline, 4 weeks, 8 weeks, 4 months, 6 months | Freiburger Mindfulness Inventory short form (FMI short form; Walach, Buchheld, Buttenmüller, Kleinknecht, \& Schmidt, 2006), scores 0-42, higher scores indicate improvement |
| Secondary | Self-compassion | baseline, 4 weeks, 8 weeks, 4 months, 6 months | Self-Compassion Scale short form (SCS short form; Raes, Pommier, Neff, \& Van Gucht, 2011; German version Hupfeld \& Ruffieux, 2011), scores 12-60, items have different polarity |
| Secondary | Breathlessness catastrophizing | baseline, 4 weeks, 8 weeks, 4 months, 6 months | Breathlessness Catastrophizing Scale (BCS; Solomon et al., 2015; German version adapted analogue to Pain Catastrophizing Scale Meyer, Sprott, \& Mannion, 2008), scores 0-52, lower scores indicate improvement |
1 to 10 of 14Source ClinicalTrials.gov
See all 14 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 40420253 | DERIVED |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests1
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as |
|---|---|
| Stroop Color-Word Test | Secondary outcome |
Source ConductCognition
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT04769505
GET https://conductscience.org/api/trials/v1/NCT04769505/registered